Skip to content
LongevityGrade CPreclinical or uncontrolled3 primary sources

MOTS-c

Also known as mitochondrial ORF of the 12S rRNA type-c · mitochondrial-derived peptide MOTS-c

A 16-amino-acid peptide encoded in mitochondrial DNA that acts as an exercise-mimetic metabolic regulator in mice. Human data is observational only.

Overview

MOTS-c is encoded inside mitochondrial DNA and released into circulation, where it acts as a signal to the rest of the body. When the cell is under metabolic stress it moves into the nucleus and changes which genes are switched on — a mitochondrial peptide directly instructing the nuclear genome. In mice it improves insulin sensitivity, prevents diet-induced obesity and improves physical performance in old animals. In humans, levels have been measured and correlate with exercise and metabolic health, but nobody has been given it in a trial.

Research areas

Insulin resistanceExercise physiologyMitochondrial signallingAgeing

Community-specified data

Community dosage information

Unverified
Community protocol

MOTS-C 10mg

Third-party
01Reconstitution solution
1 mL
02Dose
1 mg
03Syringe units
10 units
04Frequency
7x/week
05Cycle length
90 days
06Bacteriostatic water
1 mL
07Bottle size
10 mg
08Bottles needed
9
Track this schedule
Community protocol

MOTS-C 40mg

Third-party
01Reconstitution solution
2 mL
02Dose
1 mg
03Syringe units
5 units
04Frequency
7x/week
05Cycle length
90 days
06Bacteriostatic water
2 mL
07Bottle size
40 mg
08Bottles needed
3

Source note: Standard protocol — large bottle

Track this schedule

Not medical guidance. These third-party figures have not been independently verified, clinically reviewed, or endorsed by DB Peptide. They may be inaccurate or unsafe and should not replace product labelling or advice from a qualified clinician.

Dosing reported in the literature

Every protocol below is reproduced from a published study or approved labelling, with its source named. These are records of what was studied — not recommendations, and not a suggestion that any of them is appropriate for any person.

Protocol as reportedSource
Intraperitoneal MOTS-c in high-fat-diet mice with insulin sensitivity and body composition endpointsLee et al., Cell Metabolism 2015
Late-life intraperitoneal MOTS-c in aged mice with physical capacity endpointsReynolds et al., Nature Communications 2021

Trial status

Observational human studies of endogenous levels. No interventional human trials.

Reported safety signals

  • No human interventional safety data exists at any dose.
  • AMPK activation and metabolic reprogramming have systemic consequences that have not been characterised in people.
  • Sold through unregulated channels with unverified identity and purity.

Common questions

Is MOTS-c exercise in a syringe?

It is exercise-responsive — levels rise after exercise — and giving it to mice reproduces some metabolic adaptations. That is not the same as replacing exercise in a human, and no human has received it in a controlled study.

Primary sources

3 citations
  1. 01

    The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance

    Cell Metabolism2015

  2. 02

    MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

    Nature Communications2021

  3. 03

    Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers

    Aging2016

Medical disclaimer

This page is for informational and research purposes only. Nothing here constitutes medical advice. The compounds discussed are research chemicals. Consult a qualified clinician before starting any protocol.

How this profile was built →